TUESDAY, Sept. 17, 2024 -- A small clinical trial suggests that a duo of drugs can extend survival for people battling advanced kidney...
Vous n'êtes pas connecté
WEDNESDAY, Sept. 18, 2024 -- When given after organ-removal surgery, Keytruda brings patients battling advanced bladder cancers more time cancer-free, a new trial finds. Folks with "high-risk" bladder cancers -- tumors that had already invaded...
TUESDAY, Sept. 17, 2024 -- A small clinical trial suggests that a duo of drugs can extend survival for people battling advanced kidney...
FRIDAY, Sept. 6, 2024 -- Immunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with...
Chemotherapy before surgery improves chances of preserving critical structures like the eye and skull in patients with advanced nose and sinus...
Chemotherapy before surgery improves chances of preserving critical structures like the eye and skull in patients with advanced nose and sinus...
WEDNESDAY, Sept. 18, 2024 -- There have been 50 face transplants performed in 11 countries since the surgery was pioneered back in 2005, and long-term...
THURSDAY, Sept. 12, 2024 -- For patients with locally advanced rectal cancer pursuing organ preservation, long-course chemoradiotherapy (LCCRT) is...
THURSDAY, Sept. 12, 2024 -- For patients with locally advanced rectal cancer pursuing organ preservation, long-course chemoradiotherapy (LCCRT) is...
TUESDAY, Sept. 10, 2024 -- Omission of 5-fluorouracil (5-FU) from the first-line FOLFOX, FOLFIRI, and FOLFIRINOX regimens is not associated with...
Highlights: Chemotherapy before surgery increases organ preservation from 15% to 50% The trial provides a new tr
Data from a late-stage study shows that SMMT's experimental antibody beat Keytruda in a head-to-head setting in treating certain patients with NSCLC.